Hepatitis C treatment can be provided successfully at syringe programme sites
Bone density improves in people who switch from tenofovir DF to tenofovir alafenamide
Study finds higher than expected hepatitis C prevalence among HIV-negative gay men in Amsterdam PrEP programme
Research helps explain how vedolizumab antibody therapy leads to sustained viral remission
Fewer clinic visits improve retention in HIV care in Zambia
Finding men with HIV – and keeping them in treatment
Linkage to HIV care still challenging for young men, Botswana study finds
Several new candidates in HIV drug pipeline discussed at conference
Studies look at brain and cognitive changes in people with HIV as they age
'Test and treat' study shows second phase is finding more people with HIV and getting them onto treatment
Glecaprevir/pibrentasvir for hepatitis C can be safely administered with common antiretrovirals
Dolutegravir monotherapy fails to maintain HIV viral suppression, but dolutegravir + lamivudine looks good
DAA therapy cures most people with HIV/HCV co-infection with decompensated cirrhosis or liver transplants
D:A:D study – long-term use of darunavir/ritonavir modestly increases the risk of cardiovascular disease
Simple risk score can identify gay men who may have acute HIV infection
Researchers report case of bone marrow transplant patient off ART for 288 days without HIV rebound
New HIV capsid inhibitors show high potency and prolonged activity in early studies
